Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Merck
Johnson and Johnson
Medtronic
Mallinckrodt

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Technetium tc-99m albumin aggregated kit - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for technetium tc-99m albumin aggregated kit and what is the scope of patent protection?

Technetium tc-99m albumin aggregated kit is the generic ingredient in eight branded drugs marketed by Syncor Pharms, Pharmalucence, Ge Healthcare, Bracco, Jubilant Draximage, Mallinckrodt, and Draximage, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m albumin aggregated kit. One supplier is listed for this compound.

Summary for technetium tc-99m albumin aggregated kit
Recent Clinical Trials for technetium tc-99m albumin aggregated kit

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 2
University of WashingtonPhase 2

See all technetium tc-99m albumin aggregated kit clinical trials

US Patents and Regulatory Information for technetium tc-99m albumin aggregated kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt TECHNESCAN MAA technetium tc-99m albumin aggregated kit INJECTABLE;INJECTION 017842-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bracco MACROTEC technetium tc-99m albumin aggregated kit INJECTABLE;INJECTION 017833-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmalucence AN-MAA technetium tc-99m albumin aggregated kit INJECTABLE;INJECTION 017792-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Draximage TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT technetium tc-99m albumin aggregated kit INJECTABLE;INJECTION 017881-001 Dec 30, 1987 BS RX Yes Yes   Start Trial   Start Trial   Start Trial
Jubilant Draximage PULMOLITE technetium tc-99m albumin aggregated kit INJECTABLE;INJECTION 017776-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for technetium tc-99m albumin aggregated kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Draximage TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT technetium tc-99m albumin aggregated kit INJECTABLE;INJECTION 017881-001 Dec 30, 1987   Start Trial   Start Trial
Draximage TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT technetium tc-99m albumin aggregated kit INJECTABLE;INJECTION 017881-001 Dec 30, 1987   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Dow
Baxter
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.